ACS Chemical Biology 2018-04-19

Substrate Recognition by a Colistin Resistance Enzyme from Moraxella catarrhalis

PeterJ. Stogios, Georgina Cox, Haley L. Zubyk, Elena Evdokimova, Zdzislaw Wawrzak, Gerard D. Wright, Alexei Savchenko

Index: 10.1021/acschembio.8b00116

Full Text: HTML

Abstract

Lipid A phosphoethanolamine (PEtN) transferases render bacteria resistant to the last resort antibiotic colistin. The recent discoveries of pathogenic bacteria harboring plasmid-borne PEtN transferase (mcr) genes have illustrated the serious potential for wide dissemination of these resistance elements. The origin of mcr-1 is traced to Moraxella species co-occupying environmental niches with Enterobacteriaceae. Here, we describe the crystal structure of the catalytic domain of the chromosomally encoded colistin resistance PEtN transferase, ICRMc (for intrinsic colistin resistance) of Moraxella catarrhalis. The ICRMc structure in complex with PEtN reveals key molecular details including specific residues involved in catalysis and PEtN binding. It also demonstrates that ICRMc catalytic domain dimerization is required for substrate binding. Our structure-guided phylogenetic analysis provides sequence signatures defining potentially colistin-active representatives in this enzyme family. Combined, these results advance the molecular and mechanistic understanding of PEtN transferases and illuminate their origins.

Latest Articles:

Crystallographic Trapping of Reaction Intermediates in Quinolinic Acid Synthesis by NadA

2018-04-19

[10.1021/acschembio.7b01104]

Identification of the First Diketomorpholine Biosynthetic Pathway Using FAC-MS Technology

2018-04-17

[10.1021/acschembio.8b00024]

Dynamics, Conformational Entropy, and Frustration in Protein–Protein Interactions Involving an Intrinsically Disordered Protein Domain

2018-04-16

[10.1021/acschembio.7b01105]

O-GlcNAcase fragment discovery with fluorescence polarimetry

2018-04-11

[10.1021/acschembio.8b00183]

Structure-Based Chemical Design of Abscisic Acid Antagonists That Block PYL–PP2C Receptor Interactions

2018-04-11

[10.1021/acschembio.8b00105]

More Articles...